Your support fuels our research to #EndALS! Donate Now

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS Research News

Wednesday, November 30, 2022
What are Pharmacokinetic and Pharmacodynamic Studies?
For anyone who follows drug development closely, the terms pharmacodynamics (PD) and pharmacokinetic
read more
Friday, October 21, 2022
2022 ALS TDI Summit Presents Updates on Promising Research and Potential Treatments
Speakers included ALS TDI scientists and leaders from across the ALS space, as well as Leadership Awards honoring exemplary members of the community.
read more
Friday, October 21, 2022
How to Find, Read, and Understand a Research Paper – Even if You’re not a Scientist
Dr. Kyle Denton, Director of Cell Biology at ALS TDI, on how non-scientists can better understand scientific research papers.
read more
From trial readouts to news from our lab, you can find all of the latest ALS research news here.

ALS TDI Community Blog

Friday, November 18, 2022
Understanding the Different Types of Therapeutics
When looking at treatments in clinical trials for amyotrophic lateral sclerosis (ALS), you will encounter all these different types of potential treatments.
read more
Friday, November 18, 2022
What is the ALSFRS-r?
In order to create a standardized way to track ALS disease progression, researchers have developed a questionnaire, the Revised ALS Functional Rating Scale (ALSFRS-r).
read more
Thursday, November 17, 2022
Giving Tuesday 2022
Every year on GivingTuesday ALS TDI highlights different people in our community who have been affected by ALS, and who are sharing their stories to help advance treatments.
read more
Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Wednesday, September 28, 2022
ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala
Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research.
read more
Tuesday, March 1, 2022
Tegoprubart: AT-1501’s New Name
AT-1501, a drug invented at the ALS Therapy Development Institute (ALS TDI) and being developed by Eledon Pharmaceuticals, has a new name: tegoprubart.
read more
A complete list of press releases from the ALS Therapy Development Institute.
Follow Us
Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!
Media Contact
We'd love to share our story with you. Speak to our team about our unique approach to end ALS.